Crossing the Blood-Brain Barrier: Why Natural Transport Mechanisms Are the Smarter Route
Most biologics and even small molecules fail to cross the blood-brain barrier, leaving CNS drug delivery a persistent bottleneck. Isogenica's latest short video looks at why researchers are turning to the brain's own transport systems as a more promising path in.
Solving LNP's Liver Problem: Why Targeting Is the Next Frontier in RNA Delivery
Lipid nanoparticles have powered the RNA medicine revolution, but their default tendency to accumulate in the liver limits use beyond hepatic disease.
Exonate appoints Olav Hellebø as Chief Executive Officer
Appointment of experienced executive forms part of the Company’s strategy to build momentum across its proprietary platform and therapeutic programs targeting retinal diseasesCompany is preparing a Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disea
Precision matters: Guardtech and DryR leading the way for controlled environment provision when things get seriously tight
East Anglian contamination control specialists Guardtech are collaborating with dry room experts DryR to strengthen their overall delivery of advanced cleanroom and dry room facilities across a wide range of high-tech sectors
ARU receives £4.8m to boost innovation in the NHS
The NHS Clinical Entrepreneur Programme has already helped launch 691 start-ups.
International Patent Grants for Pain Management Technology
Plextek and Remedee Labs, the French healthtech start-up, are proud to announce that patents covering key aspects of the millimetre-wave antenna technology at the heart of Remedee’s endorphin-stimulating wristband have been granted in China, Europe, and the United States. The device has since become the first CE-marked medical device in Europe approved for the treatment of chronic pain.
Lab-grown brain-spinal cord model shows ‘irreversible’ nerve damage may be reversed
Cambridge scientists have grown miniature circuits in the lab that mimic how the brain and spinal cord connect up, which underlies our movements. They used this model to show how damage to these connections previously considered ‘irreversible’ could, in fact, be reversible.
Navigating the hidden complexity of cloud-connected medical devices
MedTech consultancy TTP explores the engineering challenges behind developing secure, reliable and clinically valuable cloud-connected medical device ecosystems.
New Sidney Altman building officially opens at Babraham Research Campus
BioMed Realty UK has today officially opened the Sidney Altman Building at the Babraham Research Campus, unveiling a state-of-the-art facility designed for the next generation of life science innovation.
CWOW 2026 draws record-breaking 5,000+ attendance from UK’s Golden Innovation Corridor and beyond
Cambridge Wide Open Week (CWOW) 2026 welcomed a record-breaking audience of more than 5,000 attendees, marking its largest edition to date and highlighting the growing strength of the UK’s Golden Innovation Corridor connecting Oxford, London and Cambridge.
Welbeck Health Partners Adopts OMED Health’s Home-Based SIBO Testing Pathway Across Its Network
Patients complete SIBO breath testing at home, with diagnosis provided by an in-house OMED Health GI doctor and results returned to Welbeck's clinicians via an online portal Home-based pathway widens patient access to SIBO testing, with doctor-reviewed diagnosis in
How to help your people be good at AI
Simple, practical actions to help close the gap between AI strategy and the everyday choices people make.
Beyond assets: access is not navigation
Reflections on the work that makes life sciences ecosystems trusted and usable.
Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA
Männedorf, Switzerland, June 24, 2026: Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging
FairJourney Bio and AbTherx Partner to Offer Fully Integrated Antibody Discovery
FairJourney Bio brings AbTherx’s Atlas transgenic mouse technologies in-house, enabling partner programmes to run from immunisation to a developability-assessed lead in one continuous workflowPartnership announced at BIO International Convention 2026, as FairJourney Bio
Entrepreneur Dr Shola Adeyemi Takes a Virtual Office at the Epicentre
Entrepreneur Dr Shola Adeyemi, who has multiple business interests, has taken a virtual office at The EpiCentre in Haverhill, to grow his two AI-powered businesses: AgriTwin Intelligence, focusing on insights from leaves, and security business CheetahSwift Security.
Addenbrooke’s innovation expands access to advanced genome testing for cancer patients nationally
A service pioneered at Addenbrooke’s Hospital that could help up to three times more cancer patients benefit from whole genome sequencing (WGS) has won a national award and been accredited for use across the UK.
Sanger scientists to receive major grants from the European Research Council
The European Research Council (ERC) has announced the winners of its latest Advanced Grant competition.
Record turnout at NeuroWorks 2026 signals growing momentum behind UK neurotechnology
More than 300 researchers, clinicians, entrepreneurs, industry leaders and investors gathered at Cambridge’s Ray Dolby Centre last week for NeuroWorks 2026: Scalable Neurotechnology – Innovation, Translation and Transformative Treatments, the flagship annual conference of Cambridge NeuroWorks, powered by the Advanced Research and Invention Agency (ARIA). The event marked a record turnout,…
TRIMTECH Therapeutics brings total seed round to $47M with additional investment of $14M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio
Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc.
Is data security your top priority?
Most IT leaders say data security is their number one concern when improving technology.
In fact, nearly seven in ten rank it at the top of the list. Yet only around a third say they feel extremely confident they would pass their next regulatory audit.
Pheno Therapeutics granted FDA IND clearance for lead multiple sclerosis therapeutic candidate PTD802
US FDA clearance enables first-in-human study of PTD802, a selective GPR17 antagonist Small molecule therapeutic designed to promote remyelination in neurological diseases such as multiple sclerosis Milestone supports Pheno Therapeutics’ clin
CQC rates East Anglian Air Ambulance’s Norwich base outstanding
East Anglian Air Ambulance (EAAA) has been rated Outstanding following a recent inspection by the Care Quality Commission (CQC) at its Norwich base.
Guardtech sponsors charity football match fundraiser to kick off latest round of community support initiatives
The Suffolk-based cleanroom construction specialists have pledged £1,000 in shirt sponsorship funds to support children’s cancer charity Be More Fab